Reference · Updated continuously

Aesthetics Stock & M&A Watch

The companies whose moves hit your margins, supply, and competition. Each is paired with why it matters to an owner and the latest filing that explains a move — never a bare number. Closes as of 2026-06-25.

+5.81%

Top mover · BHC

+1.7%

Aesthetics complex, avg move

+0.03%

Laggard · HIMS

Today's Movers

Previous close, % change — the aesthetics complex at a glance.

Injectables & Neurotoxins

ABBVAbbVie (Allergan Aesthetics)

$243.14+3.51%

Botox/Juvéderm + Allē loyalty — the bellwether; pricing/rebate moves hit every injector's margins. Latest filing: 2026-06-22T00:00:00+00:00 →

EOLSEvolus

$7.15+2.58%

Jeuveau/'Newtox' + Evolus Rewards; markets aggressively to medspas — price wars start here. Latest filing: 2026-06-12T00:00:00+00:00 →

GALDGalderma Group

private / foreign — via news

Restylane/Sculptra/Dysport(US)/Alastin — huge footprint. Swiss-listed; IR/news only.

IPNIpsen

private / foreign — via news

Dysport originator. Foreign-listed; news/IR only.

RVNCRevance Therapeutics

close pending

Daxxify (long-duration tox) + RHA fillers — the main Botox challenger; duration data shifts what owners stock.

Energy Devices & Lasers

BHCBausch Health (Solta)

$5.28+5.81%

Solta: Thermage/Fraxel/Clear+Brilliant; watch for spin-off/M&A affecting support & pricing. Latest filing: 2026-05-19T00:00:00+00:00 →

CUTRCutera

close pending

Laser systems; financial distress/turnaround = discount/used-device signals for buyers.

INMDInMode Ltd.

$14.81+0.14%

Morpheus8/RF leader; device-market bellwether — earnings signal price wars on the $100K+ gear owners finance.

VEROVenus Concept

close pending

Devices + a financial-health/M&A signal; distress here = consolidation cue.

Plastic Surgery & Implants

ESTAEstablishment Labs

$89.07+2.13%

Motiva implants; US-approval milestones = surgeon-side news + market mover. Latest filing: 2026-05-22T00:00:00+00:00 →

JNJJohnson & Johnson (Mentor)

$244.88+1.61%

Mentor implants; surface only on aesthetics-specific news, not general JNJ. Latest filing: 2026-04-28T00:00:00+00:00 →

GLP-1 / Weight-Loss (demand driver)

HIMSHims & Hers Health

$32.71+0.03%

Telehealth/compounded GLP-1 — competitor to and signal for the medspa GLP-1 market. Latest filing: 2026-06-15T00:00:00+00:00 →

LLYEli Lilly

$1127.69+0.93%

Zepbound/Mounjaro; supply/pricing & compounding-rule changes reshape what medspas can offer. Latest filing: 2026-05-20T00:00:00+00:00 →

NVONovo Nordisk

$47.64+0.49%

Wegovy/Ozempic; shortage status & compounding crackdowns = direct medspa revenue impact.

Consumer Demand Signal

ELFe.l.f. Beauty

$65.09+0.85%

Consumer aesthetic-spend proxy — is discretionary beauty spend up or down? Latest filing: 2026-05-20T00:00:00+00:00 →

ULTAUlta Beauty

$485.52+1.38%

Beauty retail + in-store services; macro demand signal for aesthetic spend. Latest filing: 2026-06-09T00:00:00+00:00 →

Supply & Distribution

HSICHenry Schein

$83.69+1.05%

Distribution; supply/pricing signal for consumables. Latest filing: 2026-05-22T00:00:00+00:00 →

PDCOPatterson Companies

close pending

Distribution; secondary supply-cost signal.

We translate these moves for you.

When one of these names makes a move that touches your business, Inside MedSpa Pro tells you what it means and what to do — not just the number.

Go Pro · $20/mo

End-of-day prices reflect the previous trading close and are for general information only — not investment advice and not a recommendation to buy or sell any security. Inside MedSpa is a general, impersonal publication for medical-aesthetics business owners. It is not individualized business, financial, medical, or legal advice. Any market or company information is general in nature and not a recommendation.